Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia

Terminated

• Conditions: Leukemia

• Registration Number: NCT01108497
• Lead Sponsor: Stanford University

Brief Summary

We will study gene and protein expression in leukemia cells of children diagnosed with acute leukemia. We hope to identify genes or proteins which can help us grade leukemia at diagnosis in order to: (a) develop better means of diagnosis and (b) more accurately choose the best therapy for each patient.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2001-07
• Study First Submitted: 2010-04-20
• Study First Submitted QC: 2010-04-21
• Study First Posted: 2010-04-22
• Primary Completion: 2015-09
• Study Completion: 2015-09
• Status Verified: 2016-06
• Last Update Submitted: 2016-06-22
• Last Update Posted: 2016-06-24

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 235

Inclusion Criteria

1. All children who present at Packard hospital with a new diagnosis or relapse of acute leukemia will be eligible. There is no bias in regards to age range, gender or ethnic background.

2. Signed informed consent

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Gene Expression	days 0, 8, 22 or 29

Trial Locations

Locations (1)

Stanford University School of Medicine; 🇺🇸 Stanford, California, United States